The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since
To encourage robust, good-faith discussion about difficult issues, STAT publishes selected Letters to the Editor received in response to First Opinion essays. Submit a Letter
Rapport Therapeutics, which emerged out of Johnson & Johnson’s neuroscience unit last year, has submitted its pitch for a Nasdaq listing. The Boston-based startup plans
The FDA has work to do to earn the confidence of certain groups of people who do not trust the agency, a study published Friday
The European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with Pfizer and BioNTech over certain components of the
The European Medicines Agency is taking aim at preterm birth drugs, with the agency’s safety committee recommending that medicines containing 17-hydroxyprogesterone caproate, also known as
Korean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the FDA rejected their drug combination for the most common form of
The Federal Trade Commission has loomed large over M&A in the biopharma industry in the last two years. The antitrust regulator attempted to block Amgen’s
Telix Pharmaceuticals, a radiopharma drug and diagnostics maker, has started its march toward a listing on the Nasdaq, submitting its initial pitch to the SEC.
Erasca is looking for a refresh as it drops several early-stage cancer assets, picks up new ones from China and raises cash to help push